SEC Company Response from Lantheus Holdings, Inc. (LNTH) (CIK 0001521036) (LNTH) — Mar 16, 2020
Lantheus Holdings, Inc. (LNTH) (CIK 0001521036)
Date: March 16, 2020 · CIK: 0001521036 · Accession: 0001193125-20-074371
AI Filing Summary & Sentiment
File numbers found in text: 333-234627
Show Raw Text
CORRESP 1 filename1.htm CORRESP Lantheus Holdings, Inc. 331 Treble Cove Road North Billerica, Massachusetts 01862 March 16, 2020 VIA EDGAR Division of Corporation Finance Office of Telecommunications Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Re: Lantheus Holdings, Inc. Amendment No. 1 to Registration Statement on Form S-4 Filed on March 16, 2020 Registration No. 333-234627 Ladies and Gentlemen: Pursuant to Rule 461 of the General Rules and Regulations of the Securities and Exchange Commission promulgated under the Securities Act of 1933, as amended, Lantheus Holdings, Inc. hereby respectfully requests that the effective date of the above-captioned Registration Statement on Form S-4, as amended (the “Registration Statement”) be accelerated to, and that the Registration Statement be declared effective at, 10:00 a.m., prevailing Eastern Time, on March 18, 2020, or as soon as practicable thereafter. Please contact Morton A. Pierce (morton.pierce@whitecase.com / telephone: (212) 819-7900), Bryan J. Luchs (bryan.luchs@whitecase.com / telephone: (212) 819-7848) or Michelle B. Rutta (michelle.rutta@whitecase.com / telephone: (212) 819-7864) of White & Case LLP with any questions and please notify one or more of them when this request for acceleration has been granted. Sincerely, Lantheus Holdings, Inc. /s/ Robert J. Marshall, Jr. Name: Robert J. Marshall, Jr. Title: Chief Financial Officer and Treasurer cc: Michael P. Duffy (Lantheus Holdings, Inc.) David M. Mims (Progenics Pharmaceuticals, Inc.) Morton A. Pierce Bryan J. Luchs Michelle B. Rutta (White & Case LLP) Reb D. Wheeler Andrew J. Noreuil (Mayer Brown LLP) Jack S. Bodner Scott F. Smith (Covington & Burling LLP)